Medit and Graphy Announce Strategic Partnership to Advance Digital Orthodontics
SEOUL, South Korea, April 25, 2025 /PRNewswire/ -- Medit, a global leader in digital dentistry solutions, and Graphy, a leading innovator in 3D printing dental materials, have officially announced a strategic partnership to accelerate advancements in the digital orthodontics market.
The partnership brings together Medit's expertise in intraoral scanning and open digital workflows with Graphy's groundbreaking material technology, including the world's first directly 3D-printed clear aligners. The two companies will co-develop next-generation orthodontic solutions that deliver greater speed, accuracy, and efficiency across every stage — from diagnosis to appliance fabrication.
By integrating their technologies, Medit and Graphy aim to enhance user experience for both clinicians and patients, enabling a more seamless and predictable digital orthodontic journey. Further areas of cooperation will be defined as the partnership evolves.
About Medit
Medit Corp. is a global leader in digital dentistry solutions, known for its cutting-edge intraoral scanners and open-platform workflow systems. Headquartered in Seoul, South Korea, Medit develops and supplies the i-Series scanners (including the i700 and i900), which are widely recognized for their speed, accuracy, and ease of use. These scanners are adopted by thousands of clinics and labs across the globe.
Through its cloud-based Medit Link platform, Medit enables seamless integration of scanning, treatment planning, and case management, empowering dental professionals with enhanced flexibility and connectivity in their digital workflows.
Medit's commitment to open architecture and intuitive software tools has positioned the company at the forefront of the digital dentistry revolution, driving accessibility and innovation across the global market.
About Graphy
Graphy Co., Ltd. is a Korea-based materials science company specializing in high-performance, biocompatible photopolymer resins specifically designed for 3D printing in digital dentistry. With its proprietary oligomer synthesis technology, Graphy independently formulates and manufactures advanced resins that offer superior mechanical properties and stability compared to conventional materials.
Under its flagship brand Tera Harz, Graphy provides material solutions for a wide range of dental applications, including shape memory clear aligners, crowns, bridges, and surgical guides.
Notably, Graphy is the first company in the world to commercialize resin for directly 3D-printed shape memory clear aligners, setting a new standard in functional dental 3D printing and leading the evolution of in-office orthodontic solutions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
2 hours ago
- Korea Herald
HCLTech Grant Americas second edition awards $1 million to three NGOs to create scalable solutions to combat climate change
NEW YORK and NOIDA, India, June 6, 2025 /PRNewswire/ -- HCLTech (NSE: (BSE: a leading global technology company, announced Osa Conservation as the winner and Daily Acts and Ocean Wise as the two runners-up of the second edition of the HCLTech Climate Action Grant in the Americas. The three non-government organizations (NGOs) will be awarded a total of $1 million to help build scalable, sustainable solutions to drive climate action across the Americas. In the second year, applications increased by more than 70%, and after several rounds of review and rigorous due diligence, HCLTech selected Osa Conservation to receive $500,000 and Daily Acts and Ocean Wise to receive $250,000 each. This year's registrations increased by 34% from the 10 eligible countries across the Americas, including Argentina, Brazil, Canada, Colombia, Costa Rica, Guatemala, Mexico, Panama, Peru and the U.S. Osa Conservation, based in Costa Rica, will focus its grant award on Climate Lifeboat corridors, which help species migrate and thrive amid climate change. By reconnecting fragmented tropical habitats, the project supports climate adaptation while safeguarding ecosystems across millions of acres. California-based Daily Acts will use its grant for its community-powered climate resilience initiative. The project blends government strategy with grassroots action to advance water management, stormwater mitigation and social infrastructure across neighborhoods in Petaluma, Calif. and beyond. Canada-based Ocean Wise will dedicate its grant to its kelp forest restoration project on the Pacific coast. By managing urchin overpopulation and combining advanced technology and ecological research, the project aims to strengthen marine biodiversity and support coastal communities. "We are excited to support this year's recipients of the HCLTech Grant Americas as they expand their innovative projects to reconnect natural habitats, boost community resilience and rejuvenate marine ecosystems across the Americas," said Dr. Nidhi Pundhir, Senior Vice President, Global CSR, HCLTech. "This year, we saw a substantial increase in applications, highlighting the urgency of mitigating the adverse effects of climate change and the importance of supporting initiatives that pave the way for a sustainable future." In its inaugural year in 2023, HCLTech Climate Action Grant in the Americas committed $5 million in grants over five years to support sustainable solutions to fight the climate crisis across the Americas. The Grant in the Americas builds on HCLTech and the HCLFoundation (HCLTech's CSR arm) focus on continuous global sustainability commitment with a total investment of over $175 million in CSR programs to date. HCLTech is consistently recognized for its commitment to making a positive difference in the environment. Through our technology and collective expertise, HCLTech was recognized as an Industry Mover by S&P Global Sustainability Yearbook 2023 for sustainable business practices and continues to partner with leading U.S.-based organizations, including Feeding America and Girl Up, to serve the broader community. For more information on HCLTech Climate Action Grant in the Americas, its mission and the application process, please visit HCLTech is a global technology company, home to more than 223,000 people across 60 countries, delivering industry-leading capabilities centered around digital, engineering, cloud and AI, powered by a broad portfolio of technology services and products. We work with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, High Tech, Semiconductor, Telecom and Media, Retail and CPG and Public Services. Consolidated revenues as of 12 months ending March 2025 totaled $13.8 billion. To learn how we can supercharge progress for you, visit Elka Ghudial, EMEA
Korea Herald
2 hours ago
- Korea Herald
Why Can China Make Rapid Progress in Artificial Intelligence?
BEIJING, June 5, 2025 /PRNewswire/ -- Finding Answers in China from In 2025, China runs in a fast lane of artificial intelligence (AI) development as the country has made a series of breakthroughs in this frontier technology. For example, DeepSeek astonished the world with its high performance and lower cost, Unitree robots showed a stunning yangko dance at the Spring Festival Gala, and Beijing held the world's first humanoid robot half-marathon in this spring. In this episode, CICG's South Korean host Kim Eunji, along with KIM Jongmoon, Chief Representative of Korea Innovation Center (KIC China), explores Beijing's Yizhuang Economic-Technological Development Area which is home to many artificial intelligence startups. They try to find out the key to their success.
Korea Herald
2 hours ago
- Korea Herald
FutureCeuticals, Inc. Announces Peer-Reviewed Publication Highlighting Cellular Health and Immune Support Benefits of vitAlign®
MOMENCE, Ill., June 5, 2025 /PRNewswire/ -- New research published in the International Journal of Molecular Sciences shows that vitAlign®, a proprietary and comprehensive healthy aging innovation from FutureCeuticals, delivers significant benefits for restoring cellular health and supporting a healthy immune response. The study highlights vitAlign's effectiveness in regulating cellular function and metabolic imbalances associated with immune stressors—from the seasonal cold and flu to more complex environmental and immune-related challenges. Researchers evaluated the impact of a low, 50 mg dose of vitAlign in medically stable adults aged 40–55 recovering from a moderate course of COVID-19, as defined by CDC guidelines. The study compared vitAlign to a 1000 mg dose of Vitamin C, focusing on key markers and processes that directly impact immune and cellular health. Results showed that vitAlign significantly reduced excessive reactive oxygen species (ROS) production in mitochondria and through the NOX2 and iNOS pathways—key mechanisms that influence immune and cellular function. Additionally, researchers observed increased levels of circulating, bioavailable nitric oxide, suggesting support for endothelial function and cardiovascular health. The authors noted that the increase in nitric oxide is likely attributable to vitAlign's ability to regulate multiple pathways of ROS production. Notably, vitAlign delivered measurable effects within 30 minutes, lasting up to three hours. In contrast, Vitamin C, which was used as a positive control, was administered at twenty times the dose and did not demonstrate comparable broad-spectrum activity. "These findings build on over a decade of published clinical research establishing vitAlign as a significant cellular health innovation, now extended directly to immune function," said J. Randal Wexler, FutureCeuticals' General Counsel and Vice President of R&D. "Previously, we've shown that vitAlign improves cellular energy efficiency and helps restore metabolic balance, both acutely and over time." Wexler added, "These new results, which compare favorably to a well-known antioxidant like Vitamin C, reinforce vitAlign's potential as a multi-faceted phytonutrient formula, providing broad support for healthy aging, cardiovascular health, and immune function. Our partners are excited about what this means for product innovation and their customers looking for daily cellular health support." About FutureCeuticals: FutureCeuticals, Inc. is the developer of vitAlign and a leader in the research, development, and manufacture of plant-based powders and extracts for the functional food, beverage, and dietary supplement markets.
